BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

918 related articles for article (PubMed ID: 35718993)

  • 1. Carbapenem antibiotic stress increases bla
    Chen H; Li N; Wang F; Wang L; Liang W
    J Clin Lab Anal; 2022 Jul; 36(7):e24519. PubMed ID: 35718993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance and virulence characteristics of four carbapenem-resistant Klebsiella pneumoniae strains coharbouring bla
    Bai J; Liu Y; Kang J; Song Y; Yin D; Wang S; Guo Q; Wang J; Duan J
    Microb Pathog; 2023 Feb; 175():105969. PubMed ID: 36610697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
    Zornic S; Petrovic I; Lukovic B
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):187-192. PubMed ID: 37535440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.
    Li J; Huang ZY; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
    BMC Microbiol; 2019 Sep; 19(1):219. PubMed ID: 31533609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant
    Zhang WX; Chen HY; Chen C; Chen JH; Wan FS; Li LX; Chen M; Zhang J
    Microb Drug Resist; 2021 Oct; 27(10):1312-1318. PubMed ID: 34297609
    [No Abstract]   [Full Text] [Related]  

  • 6. Shift in the dominant sequence type of carbapenem-resistant Klebsiella pneumonia infection from ST278-NDM-1 to ST11-KPC-2 in neonatal patients in a children's hospital in Shanghai, China, 2017-2021.
    Yin L; Lu L; He L; Wang L; Lu G; Cao Y; Zhai X; Wang C
    Int Microbiol; 2024 Jun; 27(3):871-881. PubMed ID: 37857932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of ceftazidime-avibactam resistance in bla
    Zhou J; Yan G; Tang C; Liu J; Fu P; Ding L; Yang W; Guo Y; Wang C; Lu G; Hu F
    Int J Antimicrob Agents; 2024 Jun; 63(6):107163. PubMed ID: 38570018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predominance of Klebsiella pneumoniae carbapenemase (KPC-type) gene among high-level carbapenem-resistant Klebsiella pneumoniae isolates in Baghdad, Iraq.
    Hussein NH; Mohammed Kareem S; Hussein Al-Kakei SN; Taha BM
    Mol Biol Rep; 2022 Jun; 49(6):4653-4658. PubMed ID: 35471622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas13-assisted carbapenem-resistant Klebsiella pneumoniae detection.
    Cao Y; Tian Y; Huang J; Xu L; Fan Z; Pan Z; Chen S; Gao Y; Wei L; Zheng S; Zhang X; Yu Y; Ren F
    J Microbiol Immunol Infect; 2024 Feb; 57(1):118-127. PubMed ID: 37963801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms Driving the
    Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
    mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
    Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
    Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
    J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth characterization of multidrug-resistant NDM-1 and KPC-3 co-producing
    Posteraro B; De Maio F; Motro Y; Menchinelli G; De Lorenzis D; Marano RBM; Aljanazreh B; Errico FM; Massaria G; Spanu T; Posteraro P; Moran-Gilad J; Sanguinetti M
    Microbiol Spectr; 2024 Apr; 12(4):e0330523. PubMed ID: 38411998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant
    Peng C; Feng DH; Zhan Y; Wang Q; Chen DQ; Xu Z; Yang L
    Microb Drug Resist; 2022 Jun; 28(6):698-709. PubMed ID: 35639427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
    Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization difference of typical KL1, KL2 and ST11-KL64 hypervirulent and carbapenem-resistant Klebsiella pneumoniae.
    Zhou Y; Wu C; Wang B; Xu Y; Zhao H; Guo Y; Wu X; Yu J; Rao L; Wang X; Yu F
    Drug Resist Updat; 2023 Mar; 67():100918. PubMed ID: 36610180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of KPC-2-Producing
    Su S; Li C; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Zhang J; Zhang X
    Microb Drug Resist; 2020 Sep; 26(9):1009-1018. PubMed ID: 32150494
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic analysis of the emerging carbapenem-resistant Klebsiella pneumoniae sequence type 11 harbouring Klebsiella pneumoniae carbapenemase (KPC) in Oman.
    Balushi MA; Kumar R; Al-Rashdi A; Ratna A; Al-Jabri A; Al-Shekaili N; Rani R; Sumri SA; Al-Ghabshi L; Al-Abri S; Al-Jardani A
    J Infect Public Health; 2022 Oct; 15(10):1089-1096. PubMed ID: 36116408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal dissemination of carbapenemase-producing Klebsiella pneumoniae: Two distinct sub-lineages of Sequence Type 11 carrying bla
    Lu MC; Tang HL; Chiou CS; Wang YC; Chiang MK; Lai YC
    Int J Antimicrob Agents; 2018 Nov; 52(5):658-662. PubMed ID: 29753130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.